CUVL
Clinuvel Pharmaceuticals Ltd
NASDAQAustraliaPharmaceuticals
Market capitalizationUSD 295.5MAs of 9/18/2026, 11:59:59 PM
Clinuvel Pharmaceuticals Ltd (CUVL) is a publicly traded company listed on Nasdaq Stock Market and associated with Australia. Its latest validated market capitalization is USD 295.5M. The latest available share price is $5.9. Institution currently ranks it #12,887 globally by market capitalization. Institution classifies the company in the Pharmaceuticals industry.
Global rank#12,887
Country rank#354Australia
Share price$5.9end of day
Market capUSD 295.5M
Share price$5.9
1D change+0.68%
Price history
Adjusted historical share price · USDPrice history unavailableCurrent market data remains available while historical price coverage is prepared.
Company profile
TickerCUVL
Primary listingNasdaq Stock Market
CountryAustralia
IndustryPharmaceuticals
Institution
Starting or running a U.S. company?
Institution coordinates incorporation, bookkeeping and tax preparation for modern businesses.